Sterkem Group will help refine the cannabis-based extracts identified by Verde Science's research and development efforts as effective for the treatment of specific medical conditions, into deliverable and marketable pharmaceutical formulations. The companies will share revenues from the sale of products and licensing fees.
News 
Market Data 
Discover 
